Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | AR |
| Upstream (Parents) |
|---|
| (<<) VTN → AR |
| (<<) HLF → AR |
| (<<) NR1I3 → AR |
| (<<) SALL1 → AR |
| (<<) NR1H4 → AR |
| (<<) GATA4 → AR |
| (<<) HHEX → AR |
| Downstream (Children) |
|---|
| AR → ONECUT1 (>>) |
| AR → ESR1 (>>) |
| AR → SOX5 (>>) |
| AR → ATF5 (>>) |
| AR → HOXB9 (>>) |
| AR → TEF (>>) |
| AR → TFAP2A (>>) |
| AR → NR5A2 (>>) |
| AR → TSHZ2 (>>) |
| AR → MAF (>>) |
| AR → LEF1 (>>) |
| AR → TCF3 (>>) |
| AR → T (>>) |
| AR → MAFF (>>) |
| AR → SOX9 (>>) |
| AR → CSDA (>>) |
| AR → RORC (>>) |
| AR → ZGPAT (>>) |
| AR → MLXIPL (>>) |
| AR → RORA (>>) |
| AR → MYOG (>>) |
| AR → PEG3 (>>) |
| AR → MYC (>>) |
| AR → ONECUT2 (>>) |
| AR → PROX1 (>>) |
| AR → CEBPA (>>) |
| AR → SNAPC4 (>>) |
| AR → MSL3 (>>) |
| AR → RB1 (>>) |
| AR → TCF7 (>>) |
| AR → HMGB2 (>>) |
| AR → CITED2 (>>) |
| AR → ETS1 (>>) |
| AR → HOXB5 (>>) |
